Sanofi Borrows as Credit Risk Holds at Seven-Week High in Europe

Sanofi, France’s largest drugmaker, is selling its first bonds in euros since November 2012 as credit risk held at the highest in more than seven weeks.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.